http://www.lls.org Listen to new and archived teleconferences from The Leukemia & Lymphoma Society. (c)2011 All material is the property of The Leukemia & Lymphoma Society and cannot distributed for commercial use without permission. admin@lls.org (admin@lls.org) en-us Wed, 22 May 2013 20:39:33 GMT Hipcast RSS Feeder 1.25 Health & Fitness 60 http://lls.hipcast.com/albumart/1000.1369255173.jpg http://www.lls.org The Leukemia & Lymphoma Society Listen to new and archived teleconferences from The Leukemia & Lymphoma Society concerning leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloma. no leukemia,lymphoma,myeloma,non,Hodgkin,lymphoma,Hodgkin,lymphoma,lukemia,cancer,blood,cancer Ralph De Simone desimoner@lls.org cc3807fd-886e-0090-0de8-4a726e158926 Fri, 17 May 2013 14:50:35 GMT 00:19:41 The Leukemia & Lymphoma Society Date: April 17, 2013 Speaker: Jorge Cortes, MD Topics Covered: Current treatment options for CML patients CML therapies Key elements of monitoring response to CML treatment The role of clinical trials in the advancement of CML treatment Quality of life issues for patients living with CML Communication touch points among patients and healthcare providers CML- Living with a Chronic Disease - Part 2 no CML- Living with a Chronic Disease - Part 2 Date: April 17, 2013 Speaker: Jorge Cortes, MD Topics Covered: Current treatment options for CML patients CML therapies Key elements of monitoring response to CML treatment The role of clinical trials in the advancement of CML treatment Quality of life issues for patients living with CML Communication touch points among patients and healthcare providers http://lls.hipcast.com/deluge/b9f5cbf2-36a4-cf9d-54a7-d8dc0621fac1.mp3 e88a1c4f-fea6-a995-4a32-3cd67e8b103b Fri, 17 May 2013 14:49:21 GMT 00:38:42 The Leukemia & Lymphoma Society Date: April 17, 2013 Speaker: Jorge Cortes, MD Topics Covered: Current treatment options for CML patients CML therapies Key elements of monitoring response to CML treatment The role of clinical trials in the advancement of CML treatment Quality of life issues for patients living with CML Communication touch points among patients and healthcare providers CML- Living with a Chronic Disease - Part 1 no CML- Living with a Chronic Disease - Part 1 Date: April 17, 2013 Speaker: Jorge Cortes, MD Topics Covered: Current treatment options for CML patients CML therapies Key elements of monitoring response to CML treatment The role of clinical trials in the advancement of CML treatment Quality of life issues for patients living with CML Communication touch points among patients and healthcare providers http://lls.hipcast.com/deluge/8b4d838c-a1a4-83c4-22af-5a66cf378776.mp3 af52be07-6e62-59a2-f067-cc42f43019fc Fri, 17 May 2013 14:41:41 GMT 00:26:41 The Leukemia & Lymphoma Society Date: May 1, 2013 Speaker: John C. Byrd, MD Topics Covered: CLL signs and symptoms Tests used to diagnose and stage CLL Current and emerging treatments for CLL patients Personalized CLL treatment plans Importance of clinical trials to improve CLL patient outcomes CLL side effects management and quality of life Update on CLL - Part 2 no Update on CLL - Part 2 Date: May 1, 2013 Speaker: John C. Byrd, MD Topics Covered: CLL signs and symptoms Tests used to diagnose and stage CLL Current and emerging treatments for CLL patients Personalized CLL treatment plans Importance of clinical trials to improve CLL patient outcomes CLL side effects management and quality of life http://lls.hipcast.com/deluge/d21b3b71-a6b0-25cc-114d-ca3fd34698d6.mp3 076872b8-ae79-2f5a-f9cf-0f72c11c0406 Fri, 17 May 2013 14:40:37 GMT 00:32:05 The Leukemia & Lymphoma Society Date: May 1, 2013 Speaker: John C. Byrd, MD Topics Covered: CLL signs and symptoms Tests used to diagnose and stage CLL Current and emerging treatments for CLL patients Personalized CLL treatment plans Importance of clinical trials to improve CLL patient outcomes CLL side effects management and quality of life Update on CLL - Part 1 no Update on CLL - Part 1 Date: May 1, 2013 Speaker: John C. Byrd, MD Topics Covered: CLL signs and symptoms Tests used to diagnose and stage CLL Current and emerging treatments for CLL patients Personalized CLL treatment plans Importance of clinical trials to improve CLL patient outcomes CLL side effects management and quality of life http://lls.hipcast.com/deluge/cb1e9efc-03a5-01e7-f6a0-3fa5f0071d5c.mp3 9c85fb50-ca88-3234-1dd0-9a3f36494f61 Fri, 12 Apr 2013 18:43:10 GMT 00:32:01 The Leukemia & Lymphoma Society Date: March 12, 2013 Speaker: Gail J. Roboz, MD Topics Covered: Myelodysplastic syndromes (MDS) Diagnostic tests for MDS Factors used to develop a plan for treatment Current and emerging therapies for MDS Possible treatment side effects and management The role of clinical trials in the advancement of MDS treatment for patients MDS - Diagnosis and Treatment Update - Part 1 no MDS - Diagnosis and Treatment Update - Part 1 Date: March 12, 2013 Speaker: Gail J. Roboz, MD Topics Covered: Myelodysplastic syndromes (MDS) Diagnostic tests for MDS Factors used to develop a plan for treatment Current and emerging therapies for MDS Possible treatment side effects and management The role of clinical trials in the advancement of MDS treatment for patients http://lls.hipcast.com/deluge/da740944-878e-134d-0169-5f32df06767a.mp3 1e495fe1-6190-a1cf-7774-9d8be6941762 Fri, 12 Apr 2013 18:42:16 GMT 00:26:14 The Leukemia & Lymphoma Society Date: March 12, 2013 Speaker: Gail J. Roboz, MD Topics Covered: Myelodysplastic syndromes (MDS) Diagnostic tests for MDS Factors used to develop a plan for treatment Current and emerging therapies for MDS Possible treatment side effects and management The role of clinical trials in the advancement of MDS treatment for patients MDS - Diagnosis and Treatment Update - Part 2 no MDS - Diagnosis and Treatment Update - Part 2 Date: March 12, 2013 Speaker: Gail J. Roboz, MD Topics Covered: Myelodysplastic syndromes (MDS) Diagnostic tests for MDS Factors used to develop a plan for treatment Current and emerging therapies for MDS Possible treatment side effects and management The role of clinical trials in the advancement of MDS treatment for patients http://lls.hipcast.com/deluge/be91d453-378c-01b5-b704-6ad0ad2aad9d.mp3 b2cd4d64-7aa9-3aa1-f5b7-df9b05577536 Fri, 05 Apr 2013 20:44:20 GMT 00:40:24 The Leukemia & Lymphoma Society Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials Blood Cancer Treatment - Making Informed Choices - Part 1 no Blood Cancer Treatment - Making Informed Choices - Part 1 Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3 6b087e88-d025-41ae-5093-d2da05cf332a Fri, 05 Apr 2013 20:43:51 GMT 00:14:31 The Leukemia & Lymphoma Society Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials Blood Cancer Treatment - Making Informed Choices - Part 2 no Blood Cancer Treatment - Making Informed Choices - Part 2 Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3 ab16b58a-3fdf-d65e-5a8d-9262f6306538 Fri, 01 Mar 2013 15:26:13 GMT 00:38:10 The Leukemia & Lymphoma Society Date: January 29, 2013 Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications Myeloma-The Latest on Research and Treatment from ASH Part 2 no Myeloma-The Latest on Research and Treatment from ASH Part 2 Date: January 29, 2013 Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications http://lls.hipcast.com/deluge/13eaf33e-8cd8-7fe5-c482-2cc2a77812c4.mp3 de91ff14-02d8-3472-7c21-5f5590f76b47 Fri, 01 Mar 2013 15:25:35 GMT 00:49:29 The Leukemia & Lymphoma Society Date: January 29, 2013 Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications Myeloma-The Latest on Research and Treatment from ASH Part 1 no Myeloma-The Latest on Research and Treatment from ASH Part 1 Date: January 29, 2013 Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications http://lls.hipcast.com/deluge/cfcc2f11-c0e6-2762-0a1d-8a6e0eff8296.mp3 4143aa3e-ab0c-0b92-727b-8ba8c3a96b76 Tue, 08 Jan 2013 20:27:14 GMT 00:38:51 The Leukemia & Lymphoma Society Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications Update: ASCT for Lymphoma and Myeloma Part 1 no Update: ASCT for Lymphoma and Myeloma Part 1 Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications http://lls.hipcast.com/deluge/bc8da6b8-0758-e381-c23c-2518cc57d1cc.mp3 e38609f6-d677-6023-3331-08f4b6749617 Tue, 08 Jan 2013 20:25:59 GMT 00:21:32 The Leukemia & Lymphoma Society Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications Update: ASCT for Lymphoma and Myeloma Part 2 no Update: ASCT for Lymphoma and Myeloma Part 2 Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications http://lls.hipcast.com/deluge/19f43451-7f43-17a7-2828-d9db565fbbe9.mp3 ea6d2cf6-58ac-f8a8-3a98-99f4dab8c289 Thu, 22 Dec 2011 17:24:10 GMT 00:33:50 The Leukemia & Lymphoma Society Topics Covered: Questions patients need to ask to make informed treatment decisions; Benefit-and-risk issues for standard treatments and clinical trials; Reasons for a patient to consider a clinical trial; How clinical trials are designed and monitored; Financial considerations related to cancer treatment Making Cancer Treatment Decisions Part 1 no Making Cancer Treatment Decisions Part 1 Topics Covered: Questions patients need to ask to make informed treatment decisions; Benefit-and-risk issues for standard treatments and clinical trials; Reasons for a patient to consider a clinical trial; How clinical trials are designed and monitored; Financial considerations related to cancer treatment http://lls.hipcast.com/deluge/5f76cd3f-c480-25d1-7085-14f14ebabd6d.mp3 becff273-e888-2f29-ec00-f8beadaaaad0 Thu, 22 Dec 2011 17:23:53 GMT 00:22:10 The Leukemia & Lymphoma Society Topics Covered: Questions patients need to ask to make informed treatment decisions; Benefit-and-risk issues for standard treatments and clinical trials; Reasons for a patient to consider a clinical trial; How clinical trials are designed and monitored; Financial considerations related to cancer treatment Making Cancer Treatment Decisions Part 2 no Making Cancer Treatment Decisions Part 2 Topics Covered: Questions patients need to ask to make informed treatment decisions; Benefit-and-risk issues for standard treatments and clinical trials; Reasons for a patient to consider a clinical trial; How clinical trials are designed and monitored; Financial considerations related to cancer treatment http://lls.hipcast.com/deluge/dfc66088-d03b-db6e-780a-08fe31710d23.mp3 c4a872fc-6226-0f65-4a7b-f3c4d13bd0b7 Tue, 09 Aug 2011 19:15:59 GMT 00:35:01 The Leukemia & Lymphoma Society Part II of an overview of recent advances by Dr. Edward A. Stadtmauer. Advances in Myeloma Treatment and Side Effect Mgt - Part II no Advances in Myeloma Treatment and Side Effect Mgt - Part II Part II of an overview of recent advances by Dr. Edward A. Stadtmauer. http://lls.hipcast.com/deluge/9e73fbf0-374a-fb2e-14b6-e53ff9c95f7f.mp3 bb057a49-860a-4733-cec7-ae1e0ee42f54 Sat, 06 Aug 2011 00:05:28 GMT 00:22:45 The Leukemia & Lymphoma Society Part 2 of an overview of CML for the newly diagnosed (in Spanish). CML Information for the Newly Diagnosed (Spanish), Part 2 no CML Information for the Newly Diagnosed (Spanish), Part 2 Part 2 of an overview of CML for the newly diagnosed (in Spanish). http://lls.hipcast.com/deluge/892075be-4061-7ce4-6bc1-b153ad84b2b8.mp3 9c66e78f-eef3-8a5d-d762-8970e0d98c9c Sat, 06 Aug 2011 00:02:55 GMT 00:45:34 The Leukemia & Lymphoma Society Overview of recent advances by Dr. Edward A. Stadtmauer. Advances in Myeloma Treatment and Side Effects Mgmt - Part 1 no Advances in Myeloma Treatment and Side Effects Mgmt - Part 1 Overview of recent advances by Dr. Edward A. Stadtmauer. http://lls.hipcast.com/deluge/8c03160a-4d59-d135-7434-248bd4fde9c7.mp3 7b782088-cf20-d7e3-4b5b-bd497cab960f Fri, 05 Aug 2011 23:56:25 GMT 00:17:12 The Leukemia & Lymphoma Society Part 2 of an overview of T-cell Lymphomas by Dr. Stephen Horowitz. T-cell Lymphomas, Part 2 no T-cell Lymphomas, Part 2 Part 2 of an overview of T-cell Lymphomas by Dr. Stephen Horowitz. http://lls.hipcast.com/deluge/5db01931-6435-de30-66dc-e127e4be1177.mp3 d4570e85-a000-0fae-bd62-7754ba01e648 Fri, 05 Aug 2011 23:55:23 GMT 00:33:41 The Leukemia & Lymphoma Society Part 1 of an overview of T-cell Lymphomas by Dr. Stephen Horowitz T-cell Lymphomas, Part 1 no T-cell Lymphomas, Part 1 Part 1 of an overview of T-cell Lymphomas by Dr. Stephen Horowitz http://lls.hipcast.com/deluge/467a4153-b9a1-1a0b-f8af-5d1cc047f68b.mp3 a0698384-d761-c811-ec70-76be331c1260 Fri, 05 Aug 2011 21:56:07 GMT The Leukemia & Lymphoma Society audio for Myeloma Myeloma 1 no d06df09a-4258-65cd-70b5-811ae8698cf4 Fri, 05 Aug 2011 21:15:12 GMT The Leukemia & Lymphoma Society audio LLS part 1 no 9ba53bd0-4d6b-624d-160a-11f629fc1b83 Fri, 05 Aug 2011 21:07:41 GMT The Leukemia & Lymphoma Society Audio file Part 1 no 4f060311-50b7-149c-24ce-6d091ffbad65 Fri, 05 Aug 2011 21:02:01 GMT The Leukemia & Lymphoma Society audio file Myeloma no d899f992-2776-66e9-3138-608de3aaf91f Thu, 17 Feb 2011 21:31:13 GMT 00:27:23 The Leukemia & Lymphoma Society This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Cephalon Oncology. Q&A session no AML Update: Treatment and Side Effects-Part 2 This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Cephalon Oncology. http://lls.hipcast.com/deluge/99cdf6de-a25c-6dab-190d-2c5137bb94e2.mp3 bd1ec156-661d-59bb-748f-acd484e8797b Thu, 17 Feb 2011 21:28:26 GMT 00:26:36 The Leukemia & Lymphoma Society This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Cephalon Oncology. Presentation no AML Update: Treatment and Side Effects-Part 1 This program (01-11-2011) featured Eric J. Feldman, MD, Professor of Medicine, Director, Hematological Malignancies, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Cephalon Oncology. http://lls.hipcast.com/deluge/67693536-3d75-9eb7-d38b-f9aec259fb09.mp3